Table 4 Incidence number of cases and total costs for Lyme borreliosis in Belgium. Total costs and 95% uncertainty interval
From: Lyme borreliosis in Belgium: a cost-of-illness analysis
| Â | (i) Erythema migrans | (ii) Disseminated/late LB | Total |
|---|---|---|---|
Nb cases | 11,168 (9,417–12,954) | 673 (519–867) | 11,840 (9,976–13,732) |
Nb overnight hospitalizations | 0 | 248a | 248 |
Nb day hospitalizations | 0 | 539b | 539 |
Direct medical costs | €1,379,838 (954,446–1,940,745) | €1,406,501 (1,210,178–1,645,284) | €2,786,338 (2,278,144–3,411,333) |
 Ambulatory | €1,379,838 (954,446–1,940,745) | €346,965 (215,580–529,594) | €1,726,803 (1,241,868–2,336,606) |
 Hospital | €0 | €1,032,324 (894,388–1,188,219) | €1,032,324 (894,388–1,188,219) |
 Day hospital | €0 | €27,211 (19,219–37,548) | €27,211 (19,219–37,548) |
Direct non-medical costs | €56,338 (11,223–130,773) | €155,000 (70,394–263,255) | €211,338 (108,891–341,204) |
 Travel expenses | €56,338 (11,223–130,773) | €127,563 (58,472–215,098) | €183,901 (95,605–298,909) |
 Paid non-medical help | €0 (0–0) | €27,437 (0–90,998) | €27,437 (0–90,998) |
Indirect non-medical costs (productivity loss) | €713,532 (84,747–1,595,890) | €1,880,849 (576,266–3,858,549) | €2,594,380 (1,046,331–4,805,398) |
 Ambulatory | €713,532 (84,747–1,595,890) | €1,765,836 (464,016–3,739,760) | €2,479,367 (930,220–4,687,748) |
 Hospital | €0 | €98,973 (86,376–112,134) | €98,973 (86,376–112,134) |
 Day hospital | €0 | €16,040 (16,040–16,040) | €16,040 (16,040–16,040) |
Total costs | €2,149,707 (1,299,782–3,262,206) | €3,442,349 (2,048,208–5,480,688) | €5,592,056 (3,816,810–7,979,428) |
Total cost per patient | €193 (121–284) | €5,148 (3,091–7,911) | €473 (333–654) |